Margaux Audett

Margaux Audett began their work experience as an Intern at Intellia Therapeutics, Inc. in June 2019. Margaux held this position until August 2019. Margaux then joined Jounce Therapeutics, Inc. in August 2021 as a Scientist and remained in that role until March 2023. Currently, Margaux is a Scientist II at Orbital Therapeutics, starting in May 2023.

Margaux Audett completed their education in a chronological order. Margaux earned a Bachelor of Science (BS) degree in Biology from Gettysburg College, where they attended from 2007 to 2011. Later, they pursued a Master's degree in Biomedical Research at Quinnipiac University from 2012 to 2014. Finally, they went on to complete a Doctor of Philosophy (PhD) degree in Molecular and Cellular Biology from the University of Massachusetts Amherst, where they studied from 2015 to 2021.